Amanote Research

Amanote Research

    RegisterSign In

Venlafaxine Versus Sertraline for Major Depressive Disorder

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.v61n1111c
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicinePsychiatryMental Health
Date

November 15, 2000

Authors
Thomas N. WiseMichael J. Sheridan
Publisher

Physicians Postgraduate Press, Inc


Related search

Cerebral Blood Perfusion Predicts Response to Sertraline Versus Placebo for Major Depressive Disorder in the EMBARC Trial

EClinicalMedicine
Medicine
2019English

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

Changes in BDNF Serum Levels in Patients With Major Depression Disorder (MDD) After 6 Months Treatment With Sertraline, Escitalopram, or Venlafaxine

Journal of Psychiatric Research
PsychiatryBiological PsychiatryMental Health
2009English

Temperament and Major Depressive Disorder

Annals of General Psychiatry
PsychiatryMental Health
2010English

Epigenetic Aging in Major Depressive Disorder

American Journal of Psychiatry
PsychiatryMental Health
2018English

Dental Patients With Major Depressive Disorder

Current Oral Health Reports
2014English

Subcortical Brain Alterations in Major Depressive Disorder: Findings From the ENIGMA Major Depressive Disorder Working Group

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy